Minimally Invasive Techniques in Ventral Hernioplasty
Launched by ASSIUT UNIVERSITY · Feb 2, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Minimally Invasive Techniques in Ventral Hernioplasty" is designed to study different surgical methods for repairing ventral hernias, which are bulges that can occur in the abdominal wall. The focus of the trial is to compare how well these techniques work in terms of reducing pain after surgery, preventing infections, shortening hospital stays, and avoiding complications like mesh migration (where the surgical material moves from its intended position). Researchers will also look at the pros and cons of each surgical method, including how easy they are to perform, their costs, and any technical challenges involved.
To be eligible for this trial, participants need to be at least 18 years old and able to provide informed consent. They must have a ventral hernia, which can include various types such as umbilical (belly button area), paraumbilical, epigastric (above the belly button), spigelian, or incisional hernias. However, individuals with certain conditions like inguinal hernias, previous hernia repairs, or large defects will not qualify. If you choose to participate, you can expect to receive care from experienced medical professionals and contribute to understanding the best ways to treat ventral hernias. This research could help improve surgical outcomes for many patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Able to give informed consent for inclusion in the study
- • Age of the patient : above 18 years
- • Any type of ventral hernia including umbilical,paraumbilical,epigastric,spigelian and incisional hernias
- Exclusion Criteria:
- • • Patients with inguinal hernia.
- • Strangulated or obstructed hernia.
- • Previous mesh hernia repair.
- • Loss of abdominal domain.
- • Infected or contaminated field.
- • Defect size more than 10cm.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported